部分脏栓塞对癌症患者的临床益处
Toru Beppu1,2, Toshiro Masuda1,2, Katsunori Imai2
1Department of Surgery, Yamaga City Medical Center, Yamaga, Japan.
概括
部分栓塞 (PSE) 改善了血小板数量,并通过关注脏梗塞的体积,而不仅仅是比率来减少并发症. 这种脏体积概念指导了治疗条件的选择,如肝硬化和癌症患者的 hypersplenism.
科学领域:
- 干预性放射学 干预性放射学
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
背景情况:
- 部分栓塞 (PSE) 是切除术的替代方案,用于肝硬化患者的高和静脉.
- 癌症患者的超缩症可能源于门静脉拥堵或化疗诱导的肝损伤.
- 在癌症管理中,PSE越来越多地被用作预治疗或并发治疗.
研究的目的:
- 引入关于脏梗塞体积而不是比率对于PSE结果至关重要的概念.
- 确定最佳的脏梗塞体积范围,以增加血小板数量和减少并发症.
- 根据体体积来指导PSE和腹腔镜切除术之间的选择.
主要方法:
- 在接受PSE的患者中分析脏梗塞体积和非心脏梗塞的脏体积.
- 体积参数与血小板数量变化和临床结果的相关性.
- 评估PSE在不同患者群体的疗效,包括肝硬化和癌症患者.
主要成果:
- 388540毫升的脏梗塞体积适合有效增加血小板数量和减少并发症.
- 在大规模的大病 (>700毫升) 中,非心脏病发作的脏体积显著影响血小板数量.
- 在癌症患者中,PSE有效改善过度缩,在与化学栓塞结合时,可能延长肝细胞癌的无进展生存期.
结论:
- 体积概念为优化PSE治疗提供了一个新的框架.
- 除了改善血小板数量之外,PSE还提供了更多的好处,包括增强肝功能和免疫激活.
- 准确理解和应用PSE对于其更广泛的临床采用至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K